Tipping the balance for the primary preve... [J Natl Cancer Inst. 2010] - PubMed

loading

Breast cancer incidence in the randomized PEARL trial of lasofoxifene in postmenopausal osteoporotic women. [J Natl Cancer Inst. 2010]
Breast cancer incidence in the randomized PEARL trial of lasofoxifene in postmenopausal osteoporotic women.
LaCroix AZ, Powles T, Osborne CK, Wolter K, Thompson JR, Thompson DD, Allred DC, Armstrong R, Cummings SR, Eastell R, et al. J Natl Cancer Inst. 2010 Nov 17; 102(22):1706-15. Epub 2010 Nov 4.
Third-generation SERMs may face uphill battle. [J Natl Cancer Inst. 2010]
Third-generation SERMs may face uphill battle.
Schmidt C. J Natl Cancer Inst. 2010 Nov 17; 102(22):1690-2. Epub 2010 Nov 8.
Another selective estrogen-receptor modulator for osteoporosis. [N Engl J Med. 2010]
Another selective estrogen-receptor modulator for osteoporosis.
Becker C. N Engl J Med. 2010 Feb 25; 362(8):752-4.
Review Not all selective estrogen response modulators are created equal: update on lasofoxifene. [Int J Gynecol Cancer. 2006]
Review Not all selective estrogen response modulators are created equal: update on lasofoxifene.
Goldstein SR. Int J Gynecol Cancer. 2006; 16 Suppl 2:504.
Review Who will benefit from treatment with selective estrogen receptor modulators (SERMs)? [Best Pract Res Clin Rheumatol....]
Review Who will benefit from treatment with selective estrogen receptor modulators (SERMs)?
Sambrook P. Best Pract Res Clin Rheumatol. 2005 Dec; 19(6):975-81.

Back to the future: mechanism-based, mutation-specific combination chemoprevention with a synthetic lethality approach. [Cancer Prev Res (Phila). 2011]
Back to the future: mechanism-based, mutation-specific combination chemoprevention with a synthetic lethality approach.
Meyskens FL Jr, Gerner EW. Cancer Prev Res (Phila). 2011 May; 4(5):628-32.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Tipping the balance for the primary prevention of breast cancer.
Tipping the balance for the primary prevention of breast cancer.
J Natl Cancer Inst. 2010 Nov 17 ;102(22):1683-5. doi: 10.1093/jnci/djq435. Epub 2010 Nov 4 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed